Sodium bisulfite

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Summary

Sodium bisulfite is an ingredient in parenteral nutrition products for patients with severe liver disorders.

Generic Name
Sodium bisulfite
DrugBank Accession Number
DB14015
Background

Sodium bisulfite has been used externally for parasitic skin diseases and as a gastrointestinal antiseptic.

Type
Small Molecule
Groups
Approved
Structure
Thumb
Weight
Average: 104.061
Monoisotopic: 103.954409263
Chemical Formula
HNaO3S
Synonyms
  • Bisulfite de sodium
  • Natriumbisulfit
  • Natriumhydrogensulfit
  • primäres Natriumsulfit
  • saures Natriumsulfit
  • Sodium bisulfite
  • sodium bisulphite
  • sodium hydrogen sulfite
  • sodium hydrogensulfite
External IDs
  • E222

Pharmacology

Indication

Not Available

Pharmacology
Accelerate your drug discovery research with the industry’s only fully connected ADMET dataset, ideal for:
Machine Learning
Data Science
Drug Discovery
Accelerate your drug discovery research with our fully connected ADMET dataset
Learn more
Associated Therapies
Contraindications & Blackbox Warnings
Contraindications
Contraindications & Blackbox Warnings
With our commercial data, access important information on dangerous risks, contraindications, and adverse effects.
Learn more
Our Blackbox Warnings cover Risks, Contraindications, and Adverse Effects
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Medicalerrors
Reduce medical errors
and improve treatment outcomes with our comprehensive & structured data on drug adverse effects.
Learn more
Reduce medical errors & improve treatment outcomes with our adverse effects data
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
CisplatinThe therapeutic efficacy of Cisplatin can be decreased when used in combination with Sodium bisulfite.
Interactions
Improve patient outcomes
Build effective decision support tools with the industry’s most comprehensive drug-drug interaction checker.
Learn more
Food Interactions
No interactions found.

Products

Products
Comprehensive & structured drug product info
From application numbers to product codes, connect different identifiers through our commercial datasets.
Learn more
Easily connect various identifiers back to our datasets
Learn more
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
HEPATAMINE %8 500 ML(SETLI)Sodium bisulfite (0.01 %) + Ademetionine (0.24 %) + Adenine (0.8 %) + Ascorbic acid (0.6 %) + Aspartame (0.9 %) + Biotin (0.1 %) + Calcifediol (0.9 %) + Cysteine (0.066 %) + Lysine (0.61 %) + Methionine (0.5 %) + NADH (0.45 %) + Phosphoric acid (0.115 %) + Thiamine (0.02 %) + Tryptophan (1.1 %) + Tyrosine (0.1 %) + Valine (0.77 %) + Vitamin A (0.84 %)SolutionIntravenousECZACIBAŞI-BAXTER HASTANE ÜRÜNLERİ SAN.VE TİC. A.Ş.1990-01-16Not applicableTurkey flag
HEPATAMINE %8 500 ML(SETSIZ)Sodium bisulfite (0.01 %) + Ademetionine (0.24 %) + Adenine (0.8 %) + Ascorbic acid (0.6 %) + Aspartame (0.9 %) + Biotin (0.1 %) + Calcifediol (0.9 %) + Cysteine (0.066 %) + Lysine (0.61 %) + Methionine (0.5 %) + NADH (0.45 %) + Phosphoric acid (0.115 %) + Thiamine (0.02 %) + Tryptophan (1.1 %) + Tyrosine (0.1 %) + Valine (0.77 %) + Vitamin A (0.84 %)SolutionIntravenousECZACIBAŞI-BAXTER HASTANE ÜRÜNLERİ SAN.VE TİC. A.Ş.1990-01-16Not applicableTurkey flag
LIBAVIT-K 20 MG AMPUL, 5 ADETSodium bisulfite (6 mg/2ml) + Menadione (20 mg/2ml) + Sodium chloride (12.6 mg/2ml)Injection, solutionLİBA LABORATUARLARI A.Ş.2020-08-14Not applicableTurkey flag
NEOFLEKS IZOPLEN-P % 5 DEKSTROZLU DENGELI ELEKTROLIT IÇEREN INFÜZYON IÇIN ÇÖZELTI 1000 ML SETLISodium bisulfite (0.021 g/100ml) + D-glucose (5.5 g/100ml) + Dipotassium phosphate (0.026 g/100ml) + Sodium lactate (0.26 g/100ml) + Magnesium chloride hexahydrate (0.031 g/100ml) + Potassium chloride (0.13 g/100ml)SolutionIntravenousTURKTIPSAN SAĞLIK TURİZM EĞİTİM VE TİC. A.Ş.2020-08-14Not applicableTurkey flag
NEOFLEKS IZOPLEN-P % 5 DEKSTROZLU DENGELI ELEKTROLIT IÇEREN INFÜZYON IÇIN ÇÖZELTI 1000 ML SETSIZSodium bisulfite (0.021 g/100ml) + D-glucose (5.5 g/100ml) + Dipotassium phosphate (0.026 g/100ml) + Sodium lactate (0.26 g/100ml) + Magnesium chloride hexahydrate (0.031 g/100ml) + Potassium chloride (0.13 g/100ml)SolutionIntravenousTURKTIPSAN SAĞLIK TURİZM EĞİTİM VE TİC. A.Ş.2020-08-14Not applicableTurkey flag
NEOFLEKS IZOPLEN-P % 5 DEKSTROZLU DENGELI ELEKTROLIT IÇEREN INFÜZYON IÇIN ÇÖZELTI 250 ML SETLISodium bisulfite (0.021 g/100ml) + D-glucose (5.5 g/100ml) + Dipotassium phosphate (0.026 g/100ml) + Sodium lactate (0.26 g/100ml) + Magnesium chloride hexahydrate (0.031 g/100ml) + Potassium chloride (0.13 g/100ml)SolutionIntravenousTURKTIPSAN SAĞLIK TURİZM EĞİTİM VE TİC. A.Ş.2020-08-14Not applicableTurkey flag
NEOFLEKS IZOPLEN-P % 5 DEKSTROZLU DENGELI ELEKTROLIT IÇEREN INFÜZYON IÇIN ÇÖZELTI 250 ML SETSIZSodium bisulfite (0.021 g/100ml) + D-glucose (5.5 g/100ml) + Dipotassium phosphate (0.026 g/100ml) + Sodium lactate (0.26 g/100ml) + Magnesium chloride hexahydrate (0.031 g/100ml) + Potassium chloride (0.13 g/100ml)SolutionIntravenousTURKTIPSAN SAĞLIK TURİZM EĞİTİM VE TİC. A.Ş.2020-08-14Not applicableTurkey flag
NEOFLEKS IZOPLEN-P % 5 DEKSTROZLU DENGELI ELEKTROLIT IÇEREN INFÜZYON IÇIN ÇÖZELTI 500 ML SETLISodium bisulfite (0.021 g/100ml) + D-glucose (5.5 g/100ml) + Dipotassium phosphate (0.026 g/100ml) + Sodium lactate (0.26 g/100ml) + Magnesium chloride hexahydrate (0.031 g/100ml) + Potassium chloride (0.13 g/100ml)SolutionIntravenousTURKTIPSAN SAĞLIK TURİZM EĞİTİM VE TİC. A.Ş.2020-08-14Not applicableTurkey flag
NEOFLEKS IZOPLEN-P % 5 DEKSTROZLU DENGELI ELEKTROLIT IÇEREN INFÜZYON IÇIN ÇÖZELTI 500 ML SETSIZSodium bisulfite (0.021 g/100ml) + D-glucose (5.5 g/100ml) + Dipotassium phosphate (0.026 g/100ml) + Sodium lactate (0.26 g/100ml) + Magnesium chloride hexahydrate (0.031 g/100ml) + Potassium chloride (0.13 g/100ml)SolutionIntravenousTURKTIPSAN SAĞLIK TURİZM EĞİTİM VE TİC. A.Ş.2020-08-14Not applicableTurkey flag
Nephramine Liq IVSodium bisulfite (40 mg / 100 mL) + Cysteine (13 mg / 100 mL) + Histidine (250 mg / 100 mL) + Isoleucine (560 mg / 100 mL) + Leucine (880 mg / 100 mL) + Lysine (640 mg / 100 mL) + Phenylalanine (880 mg / 100 mL) + Racemethionine (880 mg / 100 mL) + Threonine (400 mg / 100 mL) + Tryptophan (200 mg / 100 mL) + Valine (640 mg / 100 mL)SolutionIntravenousB. Braun Medical Inc.1993-12-312018-05-21Canada flag

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
TZX5469Z6I
CAS number
7631-90-5
InChI Key
DWAQJAXMDSEUJJ-UHFFFAOYSA-M
InChI
InChI=1S/Na.H2O3S/c;1-4(2)3/h;(H2,1,2,3)/q+1;/p-1
IUPAC Name
sodium hydrogen sulfite
SMILES
[Na+].OS([O-])=O

References

General References
  1. TITCK: Hepatamine (Admetionine, Adenine, Ascorbic Acid, Aspartame, Biotin, Calcifediol, Cysteine, Lysine, Methionine, NADH, Phosphoric Acid, Sodium Bisulfite. Thiamine, Tryptophan, Tyrosine, Valine, Vitamin A) Intravenous Solution [Link]
ChemSpider
571016
RxNav
1366858
ChEBI
26709
ChEMBL
CHEMBL1689285
Wikipedia
Sodium_bisulfite

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
SolutionIntravenous
Injection, solution
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
logP-1.2ChemAxon
pKa (Strongest Acidic)1.7ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count3ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area60.36 Å2ChemAxon
Rotatable Bond Count0ChemAxon
Refractivity11.21 m3·mol-1ChemAxon
Polarizability5.43 Å3ChemAxon
Number of Rings0ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Drug created on April 25, 2018 22:30 / Updated on May 14, 2021 01:06